The proband and sibling were fit and well without any systemic disorders until their 40's. II-2 presented at the age of 43 with symptoms of altered sensation and stiffness in her legs. On examination she had increased tone in both legs with brisk reflexes and extensor plantars associated with a reduction in light touch sensation and join position sense.
Both Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) of the brain and spinal cord were normal. Nerve conduction studies of the legs revealed unrecordable sensory nerve action potentials, markedly depressed compound muscle action potentials and slowed motor nerve conduction velocities, all consistent with an axonal motor and sensory polyneuropathy. CSF examination did not reveal any abnormalities. Muscle biopsy showed regular muscle fibres with no evidence of inflammation or necrosis, no ragged red fibres, normal oxidative enzyme activity, no upregulation of succinic dehydrogenase (SDH; mitochondrial enzyme), all fibers expressed cytochrome oxidase; there was no evidence of denervation/renervation and no evidence of major mitochondrial rearrangements. Genetic testing for mutations in OPA1 (sequencing and Multiplex Ligation-dependent Probe Amplification-MLPA), MFN2, mitochondrial genome mutations m.3243A>G and m.1351G>A, PolG sequencing and targeted mutation screening of PEO1 were all negative.
Clinical summary for family IT
IT proband II-3 is a 51 year-old man from the Italian island Sardinia, born to nonconsanguineous parents, who presented poor vision bilaterally since he was 2 years old. Vision deteriorated over the years and at 14 years he started having difficulties in walking progressively worsening over time, associated with distal muscular atrophy. At about the same time he also started having speech difficulties. At 18 years of age he received the diagnosis of HMSN type VI, and the neurologic exam showed bilateral optic atrophy and slight bilateral deafness, cerebellar signs including nystagmus and intentional tremor with dysmetria, ataxic and stepping gait, marked hypotrophy of antero-lateral muscles at lower limbs, pes cavus, hypopallestesia at lower limbs, brisk tendon reflexes except for Achilles reflex, which was absent. EMG showed axonal sensorimotor polyneuropathy. Brain MRI at 28 years of age was remarkable for diffuse brain and cerebellar atrophy with hyperintensity T2-weighted cerebellar white matter changes, and marked chiasm atrophy. At this time the patient also received a diagnosis of Leber Hereditary Optic Neuropathy (LHON) in combination with Charcot-Marie Tooth (CMT).
We observed this patient when he was 44, and our neurologic exam was similar to the previous demonstrating severe visual loss and optic atrophy, marked worsening of gait ataxia and steppage (standing and walking required support), marked pes cavus, hypo-apallestesia at lower limbs, with severe hypotrophic legs (see Figure 1d) , and absent deep tendon reflexes. Creatine kinase was slightly elevated (225 U/L; normal <170), and both basal and post-exercise lactic acid levels were at the upper end of the normal range (basal=20 mg/dl, post-exercise=23.6 mg/dl; normal 5.8-22 mg/dl). A brain CT scan disclosed small calcifications in the basal ganglia bilaterally. Muscle CT showed severe muscle atrophy with fibrotic and fat substitution of antero-lateral and posterior muscles of the legs. EMG confirmed a severe axonal sensorimotor polyneuropathy. Muscle biopsy was described as essentially normal except for slight neurogenic signs, in particular there were no RRF, nor COX negative fibers at histoenzymatic stains. Audiometry had selective loss for high tones. Brain MRspectroscopy showed increased lactic acid with neurodegenerative changes in the cerebellum and optic radiations. Cardiac examination and EKG were normal. Molecular investigation excluded the occurrence of the canonical LHON mtDNA mutations, as well as the complete mtDNA and OPA1 sequences were also normal.
The proband's sister II-1 has an autoimmune disorder including thyroiditis and painful fibromyalgia with muscle fatigability. Her neurologic exam was normal as well as the EMG. The family history was positive for autoimmune disorders and deafness, but the clinical syndrome of the proband was unique to him.
Clinical summary for family PL
Patients II-8, II-7, and II-5 are siblings of a consanguineous marriage (first cousins) with normal vision and development through the first 1-2 years of life. They developed progressive developmental delay and vision loss with optic nerve pallor and normal fundus, loss of gross and fine motor skills, hypertonia, hyperreflexia, and ataxia, and were wheelchair-bound by late childhood. Another sibling died in early childhood with similar symptoms per report, though not evaluated at our hospital.
Brain MRI of patient II-5 was notable for prominent extra-axial spaces at 22 months of age. By 5.2 years, bilateral cerebellar encephalomalacia developed with increased gliosis signal and vermal sparing. At 11.5 years of age, brainstem and cerebral volume loss were found along with progressive bilateral optic nerve atrophy. On MR spectroscopy, a lactate peak was noted in the cerebellum. Electromyography (EMG) performed on II-5 at age 5 revealed absent motor responses with maximal stimulation of the left tibial and bilateral peroneal nerves. However, motor responses in the right median nerve were normal. Sensory studies were normal for right median and right sural nerves, though conduction velocity of the right median was mildly slow. Sural nerve and muscle biopsy at age 8 demonstrated abnormal nerve tissue, autonomic denervation with onion-bulb morphology and rare foci of axonal demyelination and degeneration. Electron microscopy of muscle biopsy showed normal myofibrils and sarcoplasmic reticulum, abnormal peripheral nerve axons, and increased mitochondria with normal morphology (data not shown). Elevations in urine 3-methylglutaconic acid (3-MG) were detected in II-5 (13.2 mg/g creatinine; age 11.5 years), II-7 (27.8 mg/g creatinine; age 6.0 years), and II-8 (56.1 mg/g creatinine; age 13 months).
Clinical summary for family US
The index patient was born to a 26 year old gravidity 3, parity 2 mother and 34 year old father at 39 weeks by spontaneous vaginal delivery after an uncomplicated pregnancy.
The family history was noncontributory and without evidence of consanguinity. Growth parameters at birth were normal. Her delivery was complicated by meconium aspiration. Normal laboratory testing included carbohydrate deficient transferrin, very long chain fatty acid analysis, 7-dehydrocholesterol, serum copper level, TSEN54 sequencing, POLG1/2 sequencing and LAMA2 sequencing. Creatine kinase was initially elevated, but subsequently normalized. A SNP microarray revealed a de novo 2.9Mb-deletion from 6q22.33q23.2, which was considered nonpathogenic. Based on other reports of patients with a similar deletion and the genes within this area, the 6q deletion did not sufficiently explain the spectrum of findings in our patient. Supplementary Table 1 
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